TWIST BIOSCIENCE CORP (TWST)

Finn Patrick John 🟡 adjusted position in 78.4K shares (1 derivative) of Twist Bioscience Corp (TWST) at $122.58 ($12.4M) Transaction Date: Aug 18, 2026 | Filing ID: 010645

Register to leave comments

  • News bot Aug. 20, 2026, 8:06 p.m.

    🔍 Finn Patrick John (Executive)

    Company: Twist Bioscience Corp (TWST)

    Report Date: 2026-08-18

    Transaction Summary:

    • Total transactions: 9
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 23,355
    • Total shares sold: 101,710

    Detailed Transactions and Holdings:

    • Acquired 23,355 shares of Common Stock at $67.85 per share (Direct)
      Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 293,033.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 33,354 shares of Common Stock at $115.899 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 259,679.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 10,420 shares of Common Stock at $116.8202 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 249,259.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 8,868 shares of Common Stock at $117.697 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 240,391.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 4,500 shares of Common Stock at $119.04 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 235,891.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 12,917 shares of Common Stock at $119.858 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 222,974.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 6,296 shares of Common Stock at $121.007 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 216,678.00 | transaction_form_type: 4 | Footnotes: F1, F7
    • Sold 2,000 shares of Common Stock at $122.581 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 214,678.00 | transaction_form_type: 4 | Footnotes: F1, F8
    • Sold 23,355 shares of Stock Option (right to buy) at $67.85 per share (Derivative)
      Date: 2026-08-18 | Code: M | Expires: 2030-08-31 | equity_swap_involved: false | transaction_form_type: 4 | Footnotes: F1, F9

    Footnotes:

    • F1: The transactions reported on this Form 4 were affected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on May 18, 2026.
    • F2: Represents the weighted average sales price per share. The shares sold at prices ranging from $115.35 to $116.33 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F3: Represents the weighted average sales price per share. The shares sold at prices ranging from $116.37 to $117.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F4: Represents the weighted average sales price per share. The shares sold at prices ranging from $117.37to $118.19 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F5: Represents the weighted average sales price per share. The shares sold at prices ranging from $118.505 to $119.45 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F6: Represents the weighted average sales price per share. The shares sold at prices ranging from $119.515 to $120.2 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F7: Represents the weighted average sales price per share. The shares sold at prices ranging from $120.585 to $121.53 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F8: Represents the weighted average sales price per share. The shares sold at prices ranging from $122.00 to $122.815 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
    • F9: The option was 100% exercisable on December 19, 2022.